Holmes Biopharma, Inc.: Omaha Operations Resume
May 20 2008 - 8:26AM
Marketwired
SCOTTSDALE, ARIZONA announces that its clinic in Omaha Nebraska
has resumed operations with business as usual. This brief
interruption has not affected the ability of the Omaha clinic to
carry out services to clients and study participants.
The Company intends to operate the Omaha clinic at full
capacity. "We can assure our clients and shareholders that we will
continue to provide the highest quality of products and services",
stated John F. Metcalfe, President CEO Holmes Biopharma, Inc.
On behalf of the Board of Directors
John F. Metcalfe President, CEO
Certain statements in this press release constitute "forward
looking statements" within the meaning of the United States
Securities Legislation. The Company's actual results could differ
from those in the forward-looking statements. Do not construe this
information as investment advice. This is not a solicitation to buy
or sell securities. This does not purport to be a complete analysis
of the Company. Investing in securities is speculative and carries
a high degree of risk. Past performance does not guarantee future
results. Readers should consult their own independent advisers with
any investment, including any contemplated investment. All
information contained in this press release should be independently
investigated. This press release contains forward-looking
statements. These remarks involve risks and uncertainties. Risks
are not limited to quarterly fluctuations in results or the
companies' management of growth and competition. Other risks are
detailed in the Company's SEC filings. Actual results may differ
materially from such information set forth herein.
Contacts: Holmes Biopharma, Inc. John F. Metcalfe President, CEO
1-800-778-4990 Email: ir@holmesbiopharma.com Website:
www.holmesbiopharma.com
Swiftsure (CE) (USOTC:HLMB)
Historical Stock Chart
From Apr 2024 to May 2024
Swiftsure (CE) (USOTC:HLMB)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Swiftsure International Inc (CE) (OTCMarkets): 0 recent articles
More Holmes Biopharma, Inc. News Articles